Method for synthesizing 5-trifluoro methyl-2'-desugarized uridine
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- FUBANG BIO PHARMA HANGZHOU
- Publication Date
- 2007-08-29
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
Technical field:
[0001] The invention relates to the field of drug synthesis, in particular to a synthesis method of 5-trifluoromethyl-2'-deoxyuridine. Background technique:
[0002] 5-Trifluoromethyl-2'-deoxyuridine (Trifluridine), also known as trifluridine or trifluorothymidine, is clinically used as an antiviral drug and is a thymidine analog that interferes with DNA synthesis, It is effective for primary keratoconjunctivitis and recurrent keratitis caused by herpes simplex virus types I and II. At the same time, it is an important intermediate for the preparation of the compound 5-trifluoromethyl-2', 3'-dideoxyuridine (5-trifluoromethyl-2'3'-dideoxyuridine) with high specificity against hepatitis B virus body. 5-trifluoromethyl-2', 3'-dideoxyuridine was developed by Bayer, and in Chinese patent application 92102448.7, a synthetic 5-trifluoromethyl-2', 3'-dideoxyuridine was disclosed The method of glucoside, it is starting raw material with ethyl trifluoropropionate, ...